← Leaderboards
Jon Martin Lindstrom
University Of Pennsylvania
$10,344,333
Attributed
$13,903,375
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–15$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$13,903,375 · 3
By mechanism
R01$13,903,375 · 3
Top collaborators
- Paul J Kenny6 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Walter R.t. Witschey$8,933,628
- Paco E. Bravo$1,124,053
- Marie A Guerraty$3,136,382
- Peter Gariti$2,566,290
Others in their field
Top investigators on “Nicotinic Receptors”
- Marina R. Picciotto · Yale University$25,752,267
- Henry A. Lester · California Institute Of Technology$20,487,222
- Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute$17,620,368
- Paul J Kenny · Icahn School Of Medicine At Mount Sinai$17,249,281
- Lindsay H Burns · Cassava Sciences, Inc$16,572,741
- Linda P Dwoskin · University Of Kentucky$15,438,153
Research focus
Nicotinic ReceptorsXenopus OocyteNicotineCell LineNeuronsCellsMediatingAgonistResponseRodentLibrariesRattusProgramsBrainPropertyPharmaceutical PreparationsStoichiometryAntigensKnockout MiceMolecular ConformationExtracellularLaboratoriesPlayCholinergic Receptors
Grant awards (21)
Development of a5* nAChR positive allosteric modulators for tobacco dependence$1,201,163
R01 · FY2015 · DA
Development of a5* nAChR positive allosteric modulators for tobacco dependence$17,289
R01 · FY2015 · DA
Development of a5* nAChR positive allosteric modulators for tobacco dependence$1,267,308
R01 · FY2014 · DA
Development of a5* nAChR positive allosteric modulators for tobacco dependence$1,486,387
R01 · FY2013 · DA
Development of a5* nAChR positive allosteric modulators for tobacco dependence$1,552,792
R01 · FY2012 · DA
Studies using purified acetylcholine receptors$490,083
R01 · FY2012 · NS · contact PI
Development of a5* nAChR positive allosteric modulators for tobacco dependence$1,593,145
R01 · FY2011 · DA
Studies using purified acetylcholine receptors$479,322
R01 · FY2011 · NS · contact PI
Studies using purified acetylcholine receptors$483,094
R01 · FY2010 · NS · contact PI
EAMG: MIR structure and specific immunosuppressive therapy$447,425
R01 · FY2009 · NS · contact PI
EAMG: MIR structure and specific immunosuppressive therapy$434,391
R01 · FY2008 · NS · contact PI
Studies using purified acetylcholine receptors$310,811
R01 · FY2008 · NS · contact PI
EAMG: MIR structure and specific immunosuppressive therapy$434,037
R01 · FY2007 · NS · contact PI
Studies using purified acetylcholine receptors$310,728
R01 · FY2007 · NS · contact PI
EAMG: MIR structure and specific immunosuppressive therapy$432,946
R01 · FY2006 · NS · contact PI
Studies using purified acetylcholine receptors$319,077
R01 · FY2006 · NS · contact PI
Studies using purified acetylcholine receptors$326,843
R01 · FY2005 · NS
STUDIES USING PURIFIED ACETYLCHOLINE RECEPTORS$599,470
R01 · FY2003 · NS
STUDIES USING PURIFIED ACETYLCHOLINE RECEPTORS$585,646
R01 · FY2002 · NS
STUDIES USING PURIFIED ACETYLCHOLINE RECEPTORS$572,225
R01 · FY2001 · NS
STUDIES USING PURIFIED ACETYLCHOLINE RECEPTORS$559,193
R01 · FY2000 · NS